Credit cards, advertising and more: Cannabis rescheduling means business opportunities
With President Donald Trump’s executive order to reschedule marijuana, operators in the $32 billion cannabis industry are anticipating…
News December 23
Latest In: Tilray
Tilray is exiting New Zealand’s medical cannabis market to focus on Australia
Tilray Medical is leaving New Zealand's medical cannabis market to focus on its MMJ operations in Australia.
News April 25
Tilray subsidiary launches commercial cannabis flower grown in Germany
Aphria RX, a subsidiary of Tilray Brands, launched the first commercial medical cannabis flower grown at its facility…
News November 14
Canopy Growth prepares to raise $250 million for marijuana investments
Days after exercising an option to acquire a U.S.-based marijuana multistate operator, onetime billion-dollar cannabis giant Canopy Growth…
News June 7
Tilray seeks to raise $250 million for US marijuana acquisitions
Canadian cannabis and beverage alcohol company Tilray Brands is preparing for marijuana reform in the United States with…
News May 22
MedMen receiver sets date to meet with creditors after cannabis MSO’s bankruptcy filing
Creditors of cannabis operator MedMen Enterprises will meet in a few weeks as investors seek repayment for hundreds…
News April 30
Cannabis operator Tilray lowers 2024 expectations, eyes Canada tax savings
Canadian cannabis and beverage alcohol company Tilray Brands has lowered its financial guidance, reducing expectations for investors in…
News April 9
Israel launches ‘anti-dumping’ probe into Canadian cannabis companies
Israel has opened an "anti-dumping investigation" concerning the importation of medical marijuana from Canada after finding “a causal…
News January 30
Cannabis operator Tilray trims loss to $46 million in quarter on record sales
Canadian cannabis producer Tilray Brands trimmed its loss to $46.2 million (61.6 million Canadian dollars) in the second…
News January 9Featured
Latest Sponsored
